Spots Global Cancer Trial Database for Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor
Official Title: A Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Oral TT-00420 (Tinengotinib) Tablets in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Prior Treatment of Chemotherapy and FGFR Inhibitor
Study ID: NCT06057571
Conditions
Interventions
Study Description
Brief Summary: A phase II, open-label, multicenter study to evaluate the efficacy and safety of oral TT-00420 (Tinengotinib) tablets in subjects with cholangiocarcinoma who failed or relapsed to prior treatment of chemotherapy and FGFR Inhibitor.
Detailed Description: Approximately 50 subjects will be enrolled. Eligible subjects will receive tinengotinib 10 mg QD orally as the initial dose level in 21-day cycles until confirmed disease progression, intolerable toxicity, death, or withdrawal of consent.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Anhui Provincial Hospital, Hefei, Anhui, China
Peking Union Medical College Hospital, Beijing, Beijing, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Shenzhen Qianhai Shekou Free Trade Zone hospital, Shenzhen, Guangdong, China
The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Henan Cancer Hospital, Zhengzhou, Henan, China
Hubei Cancer Hospital, Wuhan, Hubei, China
Zhongnan hospital of Wuhan University, Wuhan, Hubei, China
Hunan Cancer Hospital, Changsha, Hunan, China
Hunan Cancer Hospital, Changsha, Hunan, China
Hunan Provincial People's Hospital, Changsha, Hunan, China
Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China
Jilin Cancer Hospital, Changchun, Jilin, China
Liaoning Cancer Hospital, Shenyang, Liaoning, China
Central Hospital Affiliated to Shangdong First Medical University, Jinan, Shandong, China
Shandong Cancer Hospital, Jinan, Shandong, China
Eastern Hepatobiliary Surgery Hospital, Shanghai, Shanghai, China
Shanxi Cancer Hospital, Taiyuan, Shanxi, China
Sichuan Cancer Hospital, Chengdu, Sichuan, China
Yunnan Cancer Hospital, Kunming, Yunnan, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Beijing Cancer Hospital, Beijing, , China
Beijing Cancer Hospital, Beijing, , China
Beijing Tsinghua Changgeng Hospital, Beijing, , China
Fudan University Shanghai Cancer Hospital, Shanghai, , China
Zhongshan Hospital, Shanghai, , China
Tianjin medical university cancer institute & hospital, Tianjin, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
